Release Date: Mar 2017
CC: PC, MK, PBL, ICS
Kelly E. Caudle, PharmD, PhD, BCPS
CPIC Coordinator, St. Jude Children's Research Hospital; Affiliate Professor, University of Tennessee Health Science Center, Memphis, TN
Pharmacogenetics is one aspect of genomic medicine that is being actively implemented in select clinical practices. Lessons learned from pharmacogenetics implementation can inform strategies for implementing genomic medicine into multidisciplinary patient care environments. Incorporation of pharmacogenetics into clinical practice and the electronic health record (EHR) requires key components such as 1) detailed gene/drug clinical practice guidelines, such as the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines 2) the adoption of pharmacogenetics in the EHR with clinical decision support, 3) educational resources and programs for healthcare professional students, residents and clinicians. This session will focus on these key components and demonstrate how these resources can be used for successful implementation of pharmacogenetics into clinical practice and the EHR.
After attending this session, participants will be able to:
· Describe barriers to clinical implementation of pharmacogenetics.
· Describe the underlying assumptions of CPIC guidelines.
· Describe the components of a CPIC guideline.
· Illustrate how CPIC guidelines can be used by clinicians to make specific prescribing decisions for patient care when genetic information is available.
Who should attend? Practicing Pathologists, Residents, Doctoral Scientists, Pathologists' Assistants, Laboratory Managers, Bench Supervisors, Bench Technologists & Technicians, Students